Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Euphorbia resinifera
Succulente cactus-like marocaine ; source de resiniferatoxin, l'un des analgésiques naturels les plus puissants connus.
Euphorbia resinifera is a Moroccan succulent that produces resiniferatoxin, one of the most potent natural analgesics known, acting as an ultrapotent TRPV1 agonist. Its traditional uses include pain relief and as a laxative, but due to severe toxicity it is restricted to experimental research. The plant contains resiniferatoxin, euphorbol, and various triterpenes and diterpenoids.
Resiniferatoxin (RTX) is an ultrapotent agonist of the transient receptor potential vanilloid 1 (TRPV1) channel, causing initial intense activation followed by prolonged desensitization of nociceptive neurons, leading to analgesia. This functional ablation of pain-sensing nerve endings is the basis for its experimental use in chronic pain. Other diterpenoids may contribute to irritant and pro-inflammatory effects via TRPV1 and possibly other receptor pathways.
Succulente cactus-like marocaine ; source de resiniferatoxin, l'un des analgésiques naturels les plus puissants connus.
Euphorbia resinifera is a Moroccan succulent that produces resiniferatoxin, one of the most potent natural analgesics known, acting as an ultrapotent TRPV1 agonist. Its traditional uses include pain relief and as a laxative, but due to severe toxicity it is restricted to experimental research. The plant contains resiniferatoxin, euphorbol, and various triterpenes and diterpenoids.
Resiniferatoxin (RTX) is an ultrapotent agonist of the transient receptor potential vanilloid 1 (TRPV1) channel, causing initial intense activation followed by prolonged desensitization of nociceptive neurons, leading to analgesia. This functional ablation of pain-sensing nerve endings is the basis for its experimental use in chronic pain. Other diterpenoids may contribute to irritant and pro-inflammatory effects via TRPV1 and possibly other receptor pathways.